Clorox (CLX +2.4%) issues a statement saying Carl Icahn's bid to elect his nominees to the...


Clorox (CLX +2.4%) issues a statement saying Carl Icahn's bid to elect his nominees to the firm's board is "solely to advance his own agenda," and runs through a litany of reasons the current board is qualified. The question if Icahn's so-called "agenda" is merely to raise shareholder value, sits unanswered by the firm.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs